{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T16:53:01Z","timestamp":1776531181367,"version":"3.51.2"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,12]],"date-time":"2013-08-12T00:00:00Z","timestamp":1376265600000},"content-version":"vor","delay-in-days":315,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Brasileira de Psiquiatria"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.rbp.2012.07.001","type":"journal-article","created":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T15:05:08Z","timestamp":1361199908000},"page":"149-162","source":"Crossref","is-referenced-by-count":29,"special_numbering":"S2","title":["Nitric Oxide Plasma\/Serum Levels In Patients With Schizophrenia: A Systematic Review And Meta-Analysis"],"prefix":"10.1016","volume":"34","author":[{"given":"Jo\u00e3o Paulo","family":"Maia-de-Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarissa","family":"Trzesniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irismar R.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Kempton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana M. N. de","family":"Rezende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"Iego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glen B.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdar M.","family":"Dursun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Paulo","family":"Machado-de-Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime E.C.","family":"Hallak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.rbp.2012.07.001_bib0005","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1590\/S1516-44462010005000004","article-title":"Public stigma and schizophrenia in S\u00e3o Paulo city","volume":"33","author":"Peluso","year":"2011","journal-title":"Rev Bras Psiquiatr."},{"key":"10.1016\/j.rbp.2012.07.001_bib0010","doi-asserted-by":"crossref","unstructured":"Meltzer HY, Stahl SM. The dopamine hypothesis of schizophrenia: a review. Schizophrenia Bull. 1976;l2:19-76.","DOI":"10.1093\/schbul\/2.1.19"},{"issue":"3","key":"10.1016\/j.rbp.2012.07.001_bib0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1590\/S1516-44462003000300011","article-title":"Glutamatergic hypothesis of schizophrenia","volume":"25","author":"Bressan","year":"2003","journal-title":"Rev Bras Psiquitr."},{"key":"10.1016\/j.rbp.2012.07.001_bib0020","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2174\/156802606777057599","article-title":"Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia","volume":"6","author":"Lindsley","year":"2006","journal-title":"Curr Top Med Chem."},{"key":"10.1016\/j.rbp.2012.07.001_bib0025","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/archneurpsyc.1959.02340150095011","article-title":"Study of a new schizophrenomimetic drug-Sernyl","volume":"81","author":"Luby","year":"1959","journal-title":"Am Med Assoc Arch Neurol Psychiatry."},{"key":"10.1016\/j.rbp.2012.07.001_bib0030","first-page":"333","article-title":"New perspectives and directions in schizophrenia therapeutics: advances related to non-dopaminergic systems","volume":"32","author":"Al-Nuaimi","year":"2010","journal-title":"Rev Bras Psiquiatr."},{"key":"10.1016\/j.rbp.2012.07.001_bib0035","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/0024-3205(94)00337-8","article-title":"Excitatory amino acids: implications for psychiatric disorders research","volume":"55","author":"Toru","year":"1994","journal-title":"Life Sci."},{"key":"10.1016\/j.rbp.2012.07.001_bib0040","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/j.1875-9114.1996.tb02920.x","article-title":"A review of NMDA receptors and the phencyclidine model of schizophrenia","volume":"16","author":"Thornberg","year":"1996","journal-title":"Pharmacotherapy."},{"key":"10.1016\/j.rbp.2012.07.001_bib0045","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.schres.2004.05.005","article-title":"Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis","volume":"72","author":"Tuominen","year":"2005","journal-title":"Schizophr Res."},{"key":"10.1016\/j.rbp.2012.07.001_bib0050","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature01497","article-title":"Glycine binding primes NMDA receptor internalization","volume":"422","author":"Nong","year":"2003","journal-title":"Nature."},{"issue":"2\u20133","key":"10.1016\/j.rbp.2012.07.001_bib0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jad.2008.04.013","article-title":"Oxidative stress markers in bipolar disorder: a meta-analysis","volume":"111","author":"Andreazza","year":"2008","journal-title":"J Affect Disord."},{"key":"10.1016\/j.rbp.2012.07.001_bib0060","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/157340008786576553","article-title":"Role of nitric oxide in patients with schizophrenia \u2013 a systematic review of the literature","volume":"4","author":"Oliveira","year":"2008","journal-title":"Curr Psychiatry Rev."},{"key":"10.1016\/j.rbp.2012.07.001_bib0065","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0031-6997(25)06663-3","article-title":"Nitric oxide: Physiology, pathophysiology, and pharmacology","volume":"43","author":"Moncada","year":"1991","journal-title":"Pharmacol Rev."},{"key":"10.1016\/j.rbp.2012.07.001_bib0070","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s002400000145","article-title":"Testicular nitric oxide levels after unilateral testicular torsion\/detorsion in rats pretreated with caffeic acid phenethyl ester","volume":"28","author":"Koltuksuz","year":"2000","journal-title":"Urol Res."},{"key":"10.1016\/j.rbp.2012.07.001_bib0075","first-page":"594","article-title":"Collaborative study of modified AOAC method of analysis for nitrite in meat and meat products","volume":"60","author":"Fiddler","year":"1977","journal-title":"J. AOAC (J Assoc Offic Anal Chem)."},{"issue":"2","key":"10.1016\/j.rbp.2012.07.001_bib0080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00432182","article-title":"A comparison of plasma and serum levels of two tricyclic antidepressants: imipramine and desipramine","volume":"75","author":"Saady","year":"1981","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.rbp.2012.07.001_bib0085","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.arcmed.2004.06.002","article-title":"Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia","volume":"35","author":"Taneli","year":"2004","journal-title":"Arch Med Res."},{"issue":"1\u20132","key":"10.1016\/j.rbp.2012.07.001_bib0090","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jpsychires.2005.12.003","article-title":"Plasma nitric oxide and leptin values in patients with olanzapine-induced weight gain","volume":"41","author":"Atmaca","year":"2007","journal-title":"J Psychiatr Res."},{"key":"10.1016\/j.rbp.2012.07.001_bib0095","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.schres.2008.06.005","article-title":"Reduced plasma nitric oxide metabolites before and after antipsychotic treatment in patients with schizophrenia compared to controls","volume":"104","author":"Lee","year":"2008","journal-title":"Schizophr Res."},{"key":"10.1016\/j.rbp.2012.07.001_bib0100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/hup.1102","article-title":"Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: a pilot study","volume":"25","author":"Nakano","year":"2010","journal-title":"Hum Psychopharmacol Clin Exp."},{"key":"10.1016\/j.rbp.2012.07.001_bib0105","series-title":"Methods for meta-analysis in medical research","author":"Sutton","year":"2000"},{"key":"10.1016\/j.rbp.2012.07.001_bib0110","doi-asserted-by":"crossref","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327:557-60.","DOI":"10.1136\/bmj.327.7414.557"},{"issue":"2","key":"10.1016\/j.rbp.2012.07.001_bib0115","first-page":"193","volume":"11","author":"Huedo-Medina","year":"2006","journal-title":"J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods"},{"issue":"7109","key":"10.1016\/j.rbp.2012.07.001_bib0120","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ."},{"key":"10.1016\/j.rbp.2012.07.001_bib0125","first-page":"16","article-title":"Metaanal regression","volume":"42","author":"Sharp","year":"1998","journal-title":"Stata Tech Bull."},{"issue":"2","key":"10.1016\/j.rbp.2012.07.001_bib0130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000098367","article-title":"Increased levels of nitric oxide, cortisol and adrenomedullin in patients with chronic schizophrenia","volume":"16","author":"Yilmaz","year":"2006","journal-title":"Med Princ Pract."},{"issue":"1","key":"10.1016\/j.rbp.2012.07.001_bib0135","first-page":"37","article-title":"Status of plasma nitric oxide and non-enzymatic antioxidants before and after antipsychotic treatment in Nigerian patients with schizophrenia","volume":"14","author":"Arinola","year":"2009","journal-title":"J Res Med Sci."},{"issue":"3","key":"10.1016\/j.rbp.2012.07.001_bib0140","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0304-3940(96)12972-4","article-title":"Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide production","volume":"215","author":"Das","year":"1996","journal-title":"Neurosci Lett."},{"key":"10.1016\/j.rbp.2012.07.001_bib0145","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s002130100860","article-title":"Nitrite content and antioxidant enzyme levels in the blood of schizophrenic patients","volume":"158","author":"Srivastava","year":"2001","journal-title":"Psychopharmacology."},{"key":"10.1016\/j.rbp.2012.07.001_bib0150","first-page":"288","article-title":"Plasma nitrate levels in deficit versus non-deficit forms of schizophrenia","volume":"28","author":"Suzuki","year":"2003","journal-title":"J Psychiatr Neurosci."},{"issue":"12","key":"10.1016\/j.rbp.2012.07.001_bib0155","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1631\/jzus.2006.B0981","article-title":"Imbalanced free radicals and antioxidant defense systems in schizophrenia: a comparative study","volume":"7","author":"Li","year":"2006","journal-title":"J Zhejiang Univ Sci B."},{"issue":"1","key":"10.1016\/j.rbp.2012.07.001_bib0160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1515\/CCLM.2010.014","article-title":"Plasma nitrite\/nitrate concentrations in patients with schizophrenia","volume":"48","author":"Djordjevi\u0107","year":"2010","journal-title":"Clin Chem Lab Med."},{"key":"10.1016\/j.rbp.2012.07.001_bib0165","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/j.1875-9114.1996.tb02920.x","article-title":"A review of NMDA receptors and the phencyclidine model of schizophrenia","volume":"16","author":"Thornberg","year":"1996","journal-title":"Pharmacotherapy."},{"key":"10.1016\/j.rbp.2012.07.001_bib0170","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.schres.2005.05.019","article-title":"The many faces of nitric oxide in schizophrenia. A review","volume":"78","author":"Bernstein","year":"2005","journal-title":"Schizophr Res."},{"key":"10.1016\/j.rbp.2012.07.001_bib0175","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1590\/S1516-44462011000300003","article-title":"Targeting the NMDA receptor-nitric oxide-cyclic GMP pathway to develop non-dopaminergic antipsychotic medications for schizophrenia","volume":"33","author":"Oliveira","year":"2011","journal-title":"Rev Bras Psiquiatr."},{"key":"10.1016\/j.rbp.2012.07.001_bib0180","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0278-5846(02)00220-8","article-title":"The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients The possible role of oxidant\/antioxidant imbalance","volume":"26","author":"Akyol","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"10.1016\/j.rbp.2012.07.001_bib0185","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0022-3956(02)00014-6","article-title":"The possible pathophysiological role of plasma nitric oxide and adrenomedullin in schizophrenia","volume":"36","author":"Zoroglu","year":"2002","journal-title":"J Psychiatr Res."},{"key":"10.1016\/j.rbp.2012.07.001_bib0190","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000070010","article-title":"Is the arginine-nitric oxide pathway involved in the pathogenesis of schizophrenia?","volume":"47","author":"Yanik","year":"2003","journal-title":"Neuropsychobiology."},{"key":"10.1016\/j.rbp.2012.07.001_bib0195","first-page":"57","article-title":"Decreased plasma nitric oxide metabolite levels in schizophrenia","volume":"3","author":"Kim","year":"2006","journal-title":"Psychiatry Invest."},{"key":"10.1016\/j.rbp.2012.07.001_bib0200","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0920-9964(03)00070-7","article-title":"Low concentration of nitrite and nitrate in the cerebrospinal fluid from schizophrenic patients: a pilot study","volume":"68","author":"Ramirez","year":"2004","journal-title":"Schizophr Res."},{"key":"10.1016\/j.rbp.2012.07.001_bib0205","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00426324","article-title":"Cyclic GMP in the CSF of patients with schizophrenia before and after neuroleptic treatment","volume":"51","author":"Ebstein","year":"1976","journal-title":"Psychopharmacology."},{"key":"10.1016\/j.rbp.2012.07.001_bib0210","first-page":"537","article-title":"Short \u2013 and long \u2013 term effects on GABA and dopamine neurons during treatment with sulpiride","volume":"24","author":"Ziimmer","year":"1980","journal-title":"Adv Biochem Psychopharmacol."},{"key":"10.1016\/j.rbp.2012.07.001_bib0215","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1192\/bjp.142.3.288","article-title":"Low CSF concentrations of cyclic GMP in schizophrenia","volume":"142","author":"Gattaz","year":"1983","journal-title":"Br J Psychiatry."},{"key":"10.1016\/j.rbp.2012.07.001_bib0220","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1590\/S1516-44462010000200003","article-title":"Should we redefine the concept of endophenotype in schizophrenia?","volume":"32","author":"Pantelis","year":"2010","journal-title":"Rev Bras Psiquiatr."}],"container-title":["Revista Brasileira de Psiquiatria"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1516444612000244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1516444612000244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T21:30:40Z","timestamp":1745962240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1516444612000244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":44,"alternative-id":["S1516444612000244"],"URL":"https:\/\/doi.org\/10.1016\/j.rbp.2012.07.001","relation":{},"ISSN":["1516-4446"],"issn-type":[{"value":"1516-4446","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}